These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26594030)

  • 1. To counteract or to clear high-mobility group box-1 protein in influenza A (H1N1) infection? That may become the question.
    Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
    Crit Care; 2015 Nov; 19():401. PubMed ID: 26594030
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.
    Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice.
    Hatayama K; Nosaka N; Yamada M; Yashiro M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    J Med Virol; 2019 Mar; 91(3):361-369. PubMed ID: 30281823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of baicalin on in vivo anti-virus].
    Chu ZY; Chu M; Teng Y
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2413-5. PubMed ID: 18257272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamic experiment of the antivirus effect of Houttuynia cordata injection on influenza virus in mice].
    Liu FZ; Shi H; Shi YJ; Liu Y; Jin YH; Gao YJ; Guo SS; Cui XL
    Yao Xue Xue Bao; 2010 Mar; 45(3):399-402. PubMed ID: 21351520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines.
    Kosai K; Seki M; Yanagihara K; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Tashiro T; Kohno S
    J Int Med Res; 2008; 36(2):322-8. PubMed ID: 18380943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.
    Zhang XX; Wu QF; Yan YL; Zhang FL
    Inflamm Res; 2018 Feb; 67(2):179-189. PubMed ID: 29177921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
    Chen XX; Zhou HX; Qi WB; Ning ZY; Ma YJ; Li YL; Wang GC; Chen JX
    Yao Xue Xue Bao; 2015 Aug; 50(8):966-72. PubMed ID: 26668995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide.
    Nosaka N; Hatayama K; Yamada M; Fujii Y; Yashiro M; Wake H; Tsukahara H; Nishibori M; Morishima T
    J Med Virol; 2018 Jul; 90(7):1192-1198. PubMed ID: 29573352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
    Huang H; Li H; Zhou P; Ju D
    Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury.
    Wang W; Yang P; Zhong Y; Zhao Z; Xing L; Zhao Y; Zou Z; Zhang Y; Li C; Li T; Wang C; Wang Z; Yu X; Cao B; Gao X; Penninger JM; Wang X; Jiang C
    Cell Res; 2013 Apr; 23(4):577-80. PubMed ID: 23419516
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
    J Med Virol; 2017 May; 89(5):759-766. PubMed ID: 27769099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRE1 Signaling As a Putative Therapeutic Target in Influenza Virus-induced Pneumonia.
    Schmoldt C; Vazquez-Armendariz AI; Shalashova I; Selvakumar B; Bremer CM; Peteranderl C; Wasnick R; Witte B; Gattenlöhner S; Fink L; Vadász I; Morty RE; Pleschka S; Seeger W; Günther A; Herold S
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):537-540. PubMed ID: 31573336
    [No Abstract]   [Full Text] [Related]  

  • 14. An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
    Sert A; Yazar A; Odabas D; Bilgin H
    Pediatr Pulmonol; 2010 Jul; 45(7):734-6. PubMed ID: 20575093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice.
    Schouten M; de Boer JD; van der Sluijs KF; Roelofs JJ; van't Veer C; Levi M; Esmon CT; van der Poll T
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):789-94. PubMed ID: 21330465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia-infected mice.
    Chen L; Fan J; Li Y; Shi X; Ju D; Yan Q; Yan X; Han L; Zhu H
    Biomed Chromatogr; 2014 Apr; 28(4):468-74. PubMed ID: 24132661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
    Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
    Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of EM703, a new macrolide derivative, on the lung that has been damaged by influenza virus].
    Sato K; Takahashi T; Okamoto S; Muranaka H; Okamoto T; Suga M
    Jpn J Antibiot; 2004 Jun; 57 Suppl A():126-8. PubMed ID: 16108615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.